These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 34962726)

  • 1. Harm reduction: a public health approach to prison drug use.
    Belisle LA; Solano-Patricio EDC
    Int J Prison Health; 2022 Nov; 18(4):458-472. PubMed ID: 34962726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Harm reduction and viral hepatitis C in European prisons: a cross-sectional survey of 25 countries.
    Bielen R; Stumo SR; Halford R; Werling K; Reic T; Stöver H; Robaeys G; Lazarus JV
    Harm Reduct J; 2018 May; 15(1):25. PubMed ID: 29751763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Access to harm reduction and HIV-related treatment services inside Indian prisons: experiences of formerly incarcerated injecting drug users.
    Chakrapani V; Kamei R; Kipgen H; Kh JK
    Int J Prison Health; 2013; 9(2):82-91. PubMed ID: 25758440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Global State of Harm Reduction in Prisons.
    Sander G; Shirley-Beavan S; Stone K
    J Correct Health Care; 2019 Apr; 25(2):105-120. PubMed ID: 31084277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The furthest left behind: the urgent need to scale up harm reduction in prisons.
    Sander G; Murphy F
    Int J Prison Health; 2017 Sep; 13(3-4):185-191. PubMed ID: 28914120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The state of harm reduction in prisons in 30 European countries with a focus on people who inject drugs and infectious diseases.
    Stöver H; Tarján A; Horváth G; Montanari L
    Harm Reduct J; 2021 Jun; 18(1):67. PubMed ID: 34187471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Injecting drug use, sexual risk, HIV knowledge and harm reduction uptake in a large prison in Bali, Indonesia.
    Sawitri AA; Hartawan AA; Craine N; Sari AK; Septarini NW; Wirawan DN
    Int J Prison Health; 2016; 12(1):27-38. PubMed ID: 26933990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overview of harm reduction in prisons in seven European countries.
    Sander G; Scandurra A; Kamenska A; MacNamara C; Kalpaki C; Bessa CF; Laso GN; Parisi G; Varley L; Wolny M; Moudatsou M; Pontes NH; Mannix-McNamara P; Libianchi S; Antypas T
    Harm Reduct J; 2016 Oct; 13(1):28. PubMed ID: 27717368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Palliative and end-of-life care in prisons: a content analysis of the literature.
    Maschi T; Marmo S; Han J
    Int J Prison Health; 2014; 10(3):172-97. PubMed ID: 25764177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-reported injection practices among people who use drugs in French prisons: Public health implications (ANRS-Coquelicot survey 2011-2013).
    Michel L; Trouiller P; Chollet A; Molinier M; Duchesne L; Jauffret-Roustide M;
    Drug Alcohol Rev; 2018 Apr; 37 Suppl 1():S268-S276. PubMed ID: 29105203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Within-prison drug injection among HIV-infected Ukrainian prisoners: prevalence and correlates of an extremely high-risk behaviour.
    Izenberg JM; Bachireddy C; Wickersham JA; Soule M; Kiriazova T; Dvoriak S; Altice FL
    Int J Drug Policy; 2014 Sep; 25(5):845-52. PubMed ID: 24951025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The politics of harm reduction in federal prisons.
    Watson TM
    Int J Drug Policy; 2014 Sep; 25(5):916-23. PubMed ID: 25018152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reviewing harm reduction for people who inject drugs in Asia: the necessity for growth.
    Stone KA
    Harm Reduct J; 2015 Oct; 12():32. PubMed ID: 26472335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The place of syringe exchange programs in reducing harm in Canadian prisoners].
    Orsi MM; Brochu S
    Can J Public Health; 2009; 100(1):29-31. PubMed ID: 19263972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Injecting substance use in prisons in the United States: a case for needle exchange programs.
    Armstrong-Mensah E; Dada D; Rupasinghe R; Whately H
    Am J Drug Alcohol Abuse; 2021 May; 47(3):273-279. PubMed ID: 33596124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Harm reduction drug policy in Israel: what has been accomplished and what still needs to be done?
    Bonny-Noach H
    Isr J Health Policy Res; 2019 Oct; 8(1):75. PubMed ID: 31619286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drugs, prisons, and harm reduction.
    Hughes R
    J Health Soc Policy; 2003; 18(2):43-54. PubMed ID: 15189795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of harm reduction for injection drug use: A clinical and public health ethics analysis.
    Vearrier L
    Dis Mon; 2019 May; 65(5):119-141. PubMed ID: 30600096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug injection within prison in Kyrgyzstan: elevated HIV risk and implications for scaling up opioid agonist treatments.
    Azbel L; Wegman MP; Polonsky M; Bachireddy C; Meyer J; Shumskaya N; Kurmanalieva A; Dvoryak S; Altice FL
    Int J Prison Health; 2018 Sep; 14(3):175-187. PubMed ID: 30274558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using nominal group technique with people who are incarcerated in Canadian federal prisons to identify barriers and solutions to improving Prison Needle Exchange Program uptake.
    Lafferty L; Altice FL; Leone F; Stoové M; Lloyd AR; Hajarizadeh B; Kronfli N
    Int J Drug Policy; 2024 Sep; 131():104549. PubMed ID: 39141957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.